Robert Valuck, PhD, RPh
Co-Founder and CEO at OpiSafe
Professional Overview
Robert Valuck is a seasoned healthcare executive and academic leader with over 25 years of experience in the pharmaceutical industry. As the Co-Founder and CEO of OpiSafe, he leverages his deep expertise in pain management, opioid abuse prevention, and health technology to drive innovative solutions that address the opioid crisis. Concurrently, he serves as a Professor at the University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, where he has been a respected educator and researcher since 1994.
Experience Summary
Current Role
As the Co-Founder and CEO of OpiSafe, Dr. Valuck is responsible for setting the strategic vision, overseeing product development, and driving the company's growth and impact. Under his leadership, OpiSafe has emerged as a leading provider of technology-enabled solutions for opioid risk mitigation, with a focus on supporting healthcare providers, payers, and patients in navigating the complexities of pain management. He has successfully secured multiple grants and partnerships to advance the company's mission of reducing opioid-related harm and improving patient outcomes.
Career Progression
Prior to co-founding OpiSafe, Dr. Valuck held various academic and research roles at the University of Colorado, where he has been a Professor since 1994. He has authored numerous peer-reviewed publications, served on advisory boards, and received prestigious awards for his contributions to the field of pharmacy and public health. His research has focused on the epidemiology of opioid use, the development of innovative interventions, and the evaluation of policies and programs aimed at addressing the opioid crisis.
Academic Background
Dr. Valuck holds a Ph.D. in Pharmacy from the University of Colorado and is a Registered Pharmacist (RPh). His academic training and research expertise have positioned him as a leading authority in the areas of pain management, opioid abuse prevention, and the application of health information technology to address complex public health challenges.
Areas of Expertise
- Opioid use and abuse prevention
- Pain management and medication safety
- Health information technology and data analytics
- Pharmaceutical policy and regulatory compliance
- Academic leadership and interdisciplinary collaboration
Professional Impact
Dr. Valuck's work has had a significant impact on the healthcare industry and the broader community. He has been a driving force behind the development of innovative opioid risk mitigation strategies, including the OpiSafe platform, which has been adopted by healthcare organizations across the country. His research and advocacy efforts have informed policymaking and contributed to the implementation of evidence-based interventions to address the opioid crisis.
Conclusion
With his unique blend of entrepreneurial vision, academic expertise, and a deep commitment to public health, Dr. Robert Valuck is poised to continue making a lasting impact on the healthcare landscape. As the Co-Founder and CEO of OpiSafe, he is dedicated to leveraging technology and data-driven insights to transform the way healthcare providers and patients manage pain and prevent opioid-related harm.
